AI3cord: IoT devices and Artificial Intelligence to monitor and prevent frailty in older people.
The high social and economic cost of a progressively ageing global population highlights the need to promote effective models of healthy ageing that help to prevent or delay disease.
In this context, the Instituto de Biomecánica (IBV), through the Strategic Cooperation Projects programme of the Valencian Innovation Agency (AVI), has set up a consortium of Valencian stakeholders from the technology and healthcare sectors to carry out the AI3cord project, a cutting-edge R&D&I project for the development and evaluation of an innovative technological solution for the monitoring and prevention of frailty and chronicity in the elderly.
AI3cord has made it possible to create a technological platform that uses IoT devices and AI-based data analysis techniques to remotely and dynamically evaluate new indicators aimed at monitoring and preventing frailty in the elderly, with the least possible intrusion.
This project opens the door to its application in the treatment of other pathologies or chronic ailments that can benefit from remote and non-invasive monitoring technology.
AI3cord: dispositivos IoT e Inteligencia Artificial para monitorizar y prevenir la fragilidad en personas mayores.
El alto coste social y económico que supone el envejecimiento progresivo de la población mundial pone de manifiesto la necesidad de promover modelos eficaces de envejecimiento saludable que ayuden a prevenir o retrasar la enfermedad.
En este contexto, el Instituto de Biomecánica (IBV), a través del programa de Proyectos Estratégicos en Cooperación de la Agència Valenciana de la Innovació (AVI), ha movilizado un consorcio formado por agentes valencianos del sector tecnológico y asistencial para llevar a cabo el proyecto AI3cord, un proyecto de I+D+i puntero en el desarrollo y evaluación de una solución tecnológica innovadora orientada al seguimiento y prevención de la fragilidad-cronicidad en personas mayores.
AI3cord ha permitido generar una plataforma tecnológica que, a través del uso de dispositivos IoT y técnicas de análisis de datos basadas en IA, es capaz de evaluar de forma remota, dinámica y mínimamente intrusiva, nuevos indicadores orientados al seguimiento y prevención de la fragilidad en personas mayores.
Este proyecto abre las puertas a su aplicación en el abordaje de otras patologías o dolencias de carácter crónico que se pueden beneficiar de una tecnología de monitorización remota y no invasiva.
productos desde sus estadios iniciales.
The IBV enters the race to ensure the quality of natural turf pitches for the 2030 World Cup in Spain
In 2021, when FIFA published its Testing Manual for natural turf pitches as part of its Quality Programme, it laid down a new framework for the quality of natural turf playing surfaces for soccer. This framework was completed in May 2022 when it published the reference values that pitches must meet in terms of the various parameters established for their evaluation.
The Instituto de Biomecánica (IBV) has been involved in this new performance framework. In September 2022, when FIFA organized the first round-robin for the accreditation of laboratories, the IBV was awarded its first accreditation as a natural turf testing center. This accreditation, which was recently renewed in Granada, means that the IBV is now one of the world’s leading natural turf testing centers.
As a result, the IBV is currently the only center in Spain that is accredited to certify natural turf pitches, in accordance with the FIFA Quality Programme. Having just embarked on the lengthy preparations for the 2030 World Cup, where the playing surface will be the “center stage”, the IBV is ready to certify that the turf will be in top condition.
UVISA HEALTH invests in user-centered design in the development of its new products
When developing a new healthcare product, stringent technical and certification requirements must be met, and design and usability aspects must be taken into account. Involving potential users at an early stage is essential if all their needs are to be aligned holistically. People-driven innovation is a tried and tested methodology that incorporates the user perspective throughout the development process, making them active contributors from concept to product launch.
In this context, UVISA HEALTH, recognized by EIT-Health[1] as one of Europe’s most innovative healthcare start-ups, has asked the Instituto de Biomecánica (IBV) to provide a user-centered design service to generate conceptual proposals for an innovative product to treat vaginal infections. This service is seen as a comprehensive collaboration in which the designers’ perspectives, the company's experience and the input of potential end-users are brought together to design a product that not only meets the technical requirements, but also takes into account the preferences and usability demanded by the market. This article explores in detail how this synergy of vision and the commitment to participatory and user-centered design is a defining factor in the development of products from their initial stages.